IL155117A0 - Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator - Google Patents
Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activatorInfo
- Publication number
- IL155117A0 IL155117A0 IL15511701A IL15511701A IL155117A0 IL 155117 A0 IL155117 A0 IL 155117A0 IL 15511701 A IL15511701 A IL 15511701A IL 15511701 A IL15511701 A IL 15511701A IL 155117 A0 IL155117 A0 IL 155117A0
- Authority
- IL
- Israel
- Prior art keywords
- activator
- angiogenesis inhibitor
- cyclic peptides
- preparing same
- angiogenesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0012654A FR2814744B1 (fr) | 2000-10-04 | 2000-10-04 | Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese |
| PCT/FR2001/003049 WO2002028895A2 (fr) | 2000-10-04 | 2001-10-02 | Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155117A0 true IL155117A0 (en) | 2003-10-31 |
Family
ID=8854977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15511701A IL155117A0 (en) | 2000-10-04 | 2001-10-02 | Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | USRE44022E1 (no) |
| EP (1) | EP1328546B1 (no) |
| JP (1) | JP4303958B2 (no) |
| AT (1) | ATE354589T1 (no) |
| AU (2) | AU2001293948B2 (no) |
| CA (1) | CA2424506A1 (no) |
| DE (1) | DE60126802T2 (no) |
| DK (1) | DK1328546T3 (no) |
| ES (1) | ES2282293T3 (no) |
| FR (1) | FR2814744B1 (no) |
| IL (1) | IL155117A0 (no) |
| NO (1) | NO20031377L (no) |
| NZ (1) | NZ525069A (no) |
| RU (1) | RU2249599C2 (no) |
| WO (1) | WO2002028895A2 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050100963A1 (en) | 2002-03-01 | 2005-05-12 | Dyax Corporation | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| US7794693B2 (en) * | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
| US7211240B2 (en) * | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
| US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
| US8623822B2 (en) * | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| ES2692166T3 (es) * | 2003-03-03 | 2018-11-30 | Dyax Corp. | Péptidos que se unen específicamente al receptor de HGF (cMet) y usos de los mismos |
| US20090093016A1 (en) * | 2006-01-17 | 2009-04-09 | N.V. Organon | Selective Enzymatic Hydrolysis of C-Terminal Tert-Butyl Esters of Peptides |
| US8227413B2 (en) | 2006-10-19 | 2012-07-24 | Ramot At Tel-Aviv University Ltd. | Compositions and methods for inducing angiogenesis |
| US8741850B2 (en) | 2009-07-24 | 2014-06-03 | Advanced Accelerator Applications S.A. | Compounds modulators of VEGF activity and uses thereof |
| FR2969999B1 (fr) | 2011-01-03 | 2013-02-08 | Commissariat Energie Atomique | Conjugue, son procede de preparation et ses utilisations |
| WO2014034922A1 (ja) * | 2012-09-03 | 2014-03-06 | 国立大学法人東京大学 | 血管内皮細胞増殖因子受容体阻害ペプチド |
| CN103724290B (zh) * | 2013-11-15 | 2015-04-29 | 浙江大学 | 一种环肽化合物clavatustide A及其产生菌、制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4237456A1 (de) * | 1992-11-06 | 1994-05-11 | Merck Patent Gmbh | Cyclopeptide |
| DE4310643A1 (de) * | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
| US5939383A (en) * | 1996-11-15 | 1999-08-17 | Remacle; Jose | Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same |
| EP1056773A2 (en) * | 1998-02-11 | 2000-12-06 | Resolution Pharmaceuticals Inc. | Angiogenesis targeting molecules |
| AU776473C (en) * | 1999-03-11 | 2005-04-14 | Entremed, Inc | Compositions and methods for treating cancer and hyperproliferative disorders |
-
2000
- 2000-10-04 FR FR0012654A patent/FR2814744B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-02 DE DE60126802T patent/DE60126802T2/de not_active Expired - Lifetime
- 2001-10-02 CA CA002424506A patent/CA2424506A1/en not_active Abandoned
- 2001-10-02 WO PCT/FR2001/003049 patent/WO2002028895A2/fr not_active Ceased
- 2001-10-02 RU RU2003112701/04A patent/RU2249599C2/ru not_active IP Right Cessation
- 2001-10-02 IL IL15511701A patent/IL155117A0/xx unknown
- 2001-10-02 AU AU2001293948A patent/AU2001293948B2/en not_active Ceased
- 2001-10-02 EP EP01974427A patent/EP1328546B1/fr not_active Expired - Lifetime
- 2001-10-02 US US12/418,101 patent/USRE44022E1/en not_active Expired - Fee Related
- 2001-10-02 AU AU9394801A patent/AU9394801A/xx active Pending
- 2001-10-02 DK DK01974427T patent/DK1328546T3/da active
- 2001-10-02 NZ NZ525069A patent/NZ525069A/en not_active IP Right Cessation
- 2001-10-02 US US10/381,734 patent/US7199100B2/en not_active Ceased
- 2001-10-02 AT AT01974427T patent/ATE354589T1/de not_active IP Right Cessation
- 2001-10-02 JP JP2002532477A patent/JP4303958B2/ja not_active Expired - Fee Related
- 2001-10-02 ES ES01974427T patent/ES2282293T3/es not_active Expired - Lifetime
-
2003
- 2003-03-26 NO NO20031377A patent/NO20031377L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1328546B1 (fr) | 2007-02-21 |
| NZ525069A (en) | 2004-09-24 |
| EP1328546A2 (fr) | 2003-07-23 |
| NO20031377L (no) | 2003-05-02 |
| US20040092434A1 (en) | 2004-05-13 |
| DK1328546T3 (da) | 2007-06-04 |
| CA2424506A1 (en) | 2002-04-11 |
| DE60126802T2 (de) | 2007-11-08 |
| JP2004510784A (ja) | 2004-04-08 |
| WO2002028895A2 (fr) | 2002-04-11 |
| AU2001293948B2 (en) | 2005-11-03 |
| DE60126802D1 (de) | 2007-04-05 |
| USRE44022E1 (en) | 2013-02-19 |
| ES2282293T3 (es) | 2007-10-16 |
| JP4303958B2 (ja) | 2009-07-29 |
| RU2249599C2 (ru) | 2005-04-10 |
| ATE354589T1 (de) | 2007-03-15 |
| FR2814744A1 (fr) | 2002-04-05 |
| WO2002028895A3 (fr) | 2002-06-06 |
| NO20031377D0 (no) | 2003-03-26 |
| AU9394801A (en) | 2002-04-15 |
| US7199100B2 (en) | 2007-04-03 |
| FR2814744B1 (fr) | 2002-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL155117A0 (en) | Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator | |
| DK1210430T3 (da) | MUC-1-afledte peptider | |
| DE69713112D1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen | |
| AU9315398A (en) | Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response | |
| DE60142646D1 (en) | Fusionprotein | |
| PT1165115E (pt) | Modulacao da permeabilidade vascular por meio dos activadores do receptor tie2 | |
| ZA946872B (en) | Enzyme inhibitors | |
| NO942110L (no) | Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav | |
| DE69804839D1 (de) | Cd8 als inhibitor des zellulären immunsystems | |
| MXPA03005218A (es) | Peptidos y/o proteinas y uso de los mismos para la produccion de un medicamento terapeutico y/o profilactico. | |
| DE69627191D1 (de) | Bradikininanaloge als selektive thrombininhibitoren | |
| IL175319A0 (en) | Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof | |
| AU3850997A (en) | Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines | |
| AU2001293948A1 (en) | Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator | |
| IL142709A0 (en) | Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof | |
| AU1521500A (en) | Inhibition of angiogenesis by peptide analogs of high molecular weight kininogendomain | |
| NZ511618A (en) | Kininogen fragment 2 peptides with the formula of at least X-His-Lys-X-Lys-X | |
| CO5271650A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia | |
| DK0853484T3 (da) | Hidtil ukendte MU-opioid-receptorligander: agonister og antagonister | |
| NZ511166A (en) | Genes that increase the production of HMG-CoA reductase inhibitor, ML-236B | |
| ATE283914T1 (de) | Iga1-protease fragment als trägerpeptid | |
| ATE401408T1 (de) | Tapetum-spezifische promotoren | |
| EP1362915A4 (en) | FROM NOMURAEA RILEYI COMMUNICATING ECDYSTEROID-22-OXIDASE AND SYSTEM FOR MOISTURIZING HORMONE INACTIVATION THEREWITH | |
| Gromet-Elhanan et al. | Chemical Modification of Essential Amino-Acid Residues in the Chromatophore F1-ATPase and Its Isolated β-Subunit | |
| DE69927524D1 (de) | Topoisomerase-ii inhibitoren |